SCHEMBL7614212

SCHEMBL7614212

O=C(Nc1nnc(Br)s1)c1c(O)c2ccc(Cl)cc2oc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 5/20 0.41
▸ MAPT P10636 8/20 0.40
▸ HPGD P15428 3/20 0.40
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NQO1 P15559 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7616962 0.92 POLB (0.43) POLBMAPTHPGDCA1CA2
SCHEMBL9273892 0.85 RAB9A (0.48) HPGDKMT2AMEN1NPC1RAB9A
SCHEMBL7610904 0.85 MAPT (0.40) POLBMAPTHPGDCA1CA2
SCHEMBL7618641 0.85 MEN1 (0.52) POLBMAPTHPGDKMT2AMEN1
SCHEMBL7617345 0.85 CA1 (0.47) POLBMAPTHPGDCA1CA2
SCHEMBL7613159 0.85 MEN1 (0.43) POLBMAPTHPGDCA1CA2
SCHEMBL9203805 0.85 L3MBTL1 (0.54) POLBHPGDKMT2AMEN1NPC1
SCHEMBL7612894 0.85 CA1 (0.56) CA1CA2CA12CA9
SCHEMBL9202732 0.84 CA12 (0.51) POLBMAPTHPGDKMT2AMEN1
SCHEMBL9200971 0.84 MEN1 (0.43) POLBMAPTHPGDCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869785-B1 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS UPJOHN CO (US) 2002-08-28 — — EP claimed
EP-0869785-B1 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS UPJOHN CO (US) 2002-08-28 — — EP disclosed
EP-0869785-A1 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF DIABETES MELLITUS PHARMACIA & UPJOHN COMPANY (US) 1998-10-14 — — EP disclosed
WO-1997018808-A1 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF DIABETES MELLITUS PHARMACIA & UPJOHN COMPANY (US) 1997-05-29 — — WO disclosed
Send feedback